• A friendly and supportive community, register today. Our forums use a separate account system.

Australia From visions of global leadership to an asset sale: where did it go wrong for Althea’s medical aspirations?

exit1-1-300x150.jpg


With Althea calling time on its Australian pharma business, Cannabiz chief correspondent Steve Jones analyses what […]

The post From visions of global leadership to an asset sale: where did it go wrong for Althea’s medical aspirations? appeared first on Cannabiz.

Continue reading...
 
Click to expand...

  Similar Discussions (Automatically Generated)

Business of Cannabis
  • Article Article
USA OCT Announces Exclusive Joint Development Agreement With Ex-Google AI Experts, Hypatia AI to Develop an AI-Enabled Asset to Scale Its Drug Discovery P
Replies
0
Views
280
Business of Cannabis
Business of Cannabis
Business of Cannabis
  • Article Article
Europe Ananda Get Ethics Approval for Australian Clinical Study, Synbiotic Launches Germany’s First THC-Pastille, & More from Stenocare
Replies
0
Views
71
Business of Cannabis
Business of Cannabis
Business of Cannabis
  • Article Article
USA International Experts Gather to Shape the Future of Cannabis Legislation at the Inaugural Global Cannabis Regulatory Summit
Replies
0
Views
113
Business of Cannabis
Business of Cannabis
Business of Cannabis
  • Article Article
Europe Akanda Sells UK’s Canmart as it Pivots Away From Cannabis, Argent Bio Seeks Deals for Malta Facility, & Chill Brands to Raise £1m
Replies
0
Views
182
Business of Cannabis
Business of Cannabis
Business of Cannabis
  • Article Article
Canada Organigram Gets Final Investment From Tobacco Giant, Kanabo Sees Double Digit Revenue Increase, & More From Curity Pharma
Replies
0
Views
182
Business of Cannabis
Business of Cannabis
Back
Top